Role of Betaglycan in TGF-β Signaling and Wound Healing in Human Endometriotic Epithelial Cells and in Endometriosis.
SMAD2/3
TGF-βs
betaglycan
endometriosis
wound healing
Journal
Biology
ISSN: 2079-7737
Titre abrégé: Biology (Basel)
Pays: Switzerland
ID NLM: 101587988
Informations de publication
Date de publication:
26 Mar 2022
26 Mar 2022
Historique:
received:
18
02
2022
revised:
15
03
2022
accepted:
22
03
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
24
4
2022
Statut:
epublish
Résumé
Endometriosis is characterized by the presence of ectopic endometrium most often in the pelvis. The transforming growth factor-beta (TGF-β) superfamily is also involved in the pathogenesis; however, betaglycan (BG, syn. TGF-β type III receptor) as an important co-receptor was not studied. We analyzed mainly BG ectodomain shedding because released soluble BG (sBG) often antagonizes TGF-β signaling. Furthermore, we studied the role of TGF-βs and BG in wound healing and evaluated the suitability of BG measurements in serum and endocervical mucus for non-invasive diagnosis of endometriosis. Evaluation of the BG shedding and signaling pathways involved as well as wound healing was performed with enzyme-linked immune assays (ELISAs), reverse transcription-quantitative polymerase chain reaction (RT-qPCR), small interfering RNA (siRNA) knockdown, and scratch assays with human endometriotic epithelial cells. TGF-β1/2 stimulation resulted in a significant dose-dependent reduction in BG shedding in endometriotic cells, which was TGF-β/activin receptor-like kinase-5 (ALK-5)/mother against decapentaplegic homolog3 (SMAD3)- but not SMAD2-dependent. Inhibition of matrix metalloproteinases (MMPs) using the pan-MMP inhibitor GM6001 and tissue inhibitor of MMPs (TIMP3) equally attenuated BG shedding, signifying the involvement of MMPs in shedding. Likewise, recombinant BG moderately reduced the secretion of TGF-β1/2 and wound healing of endometriotic cells. TGF-β1 significantly enhanced the secretion of MMP2 and MMP3 and moderately promoted wound healing. In order to evaluate the role of BG in endometriosis, serum (n = 238) and mucus samples (n = 182) were analyzed. Intriguingly, a significant reduction in the levels of sBG in endocervical mucus but not in the serum of endometriosis patients compared to controls was observed. Collectively, these observations support a novel role for BG in the pathophysiology of endometriosis.
Identifiants
pubmed: 35453712
pii: biology11040513
doi: 10.3390/biology11040513
pmc: PMC9027931
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : German Academic Exchange Service
ID : 91731459 and 91560545
Références
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Nov;1863(11):1369-1377
pubmed: 30591146
Carcinogenesis. 2008 Mar;29(3):528-35
pubmed: 18174241
Hum Reprod. 2010 Jan;25(1):101-9
pubmed: 19892717
Biochim Biophys Acta. 2011 Feb;1813(2):332-9
pubmed: 21167215
Nat Protoc. 2007;2(2):329-33
pubmed: 17406593
Carcinogenesis. 2010 Feb;31(2):175-83
pubmed: 19955393
Mol Endocrinol. 2009 Apr;23(4):539-48
pubmed: 19164448
J Cell Sci. 2001 Dec;114(Pt 24):4359-69
pubmed: 11792802
J Biol Chem. 2004 Feb 27;279(9):7721-33
pubmed: 14672946
J Immunol. 2010 Jul 15;185(2):842-55
pubmed: 20548029
Prostate. 2007 Feb 15;67(3):301-11
pubmed: 17192875
J Clin Med. 2020 Sep 24;9(10):
pubmed: 32987826
Biochem J. 2001 Apr 1;355(Pt 1):215-22
pubmed: 11256966
Nat Rev Dis Primers. 2018 Jul 19;4(1):9
pubmed: 30026507
J Cell Biol. 1989 Dec;109(6 Pt 1):3137-45
pubmed: 2592419
Endocrinology. 2009 Apr;150(4):1904-11
pubmed: 19022896
Am J Pathol. 2001 Nov;159(5):1839-52
pubmed: 11696444
Oncogene. 2002 May 16;21(22):3541-51
pubmed: 12032856
Eur J Endocrinol. 2005 Feb;152(2):277-84
pubmed: 15745937
J Proteomics. 2015 Jan 30;114:182-96
pubmed: 25449831
Nature. 1998 Jun 25;393(6687):786-90
pubmed: 9655392
J Biol Chem. 2001 Jun 8;276(23):19945-53
pubmed: 11262418
Cancer Res. 1999 Oct 1;59(19):5041-6
pubmed: 10519421
EMBO J. 1999 Mar 1;18(5):1280-91
pubmed: 10064594
Sci Signal. 2019 Feb 26;12(570):
pubmed: 30808818
Exp Ther Med. 2020 Mar;19(3):1617-1625
pubmed: 32104212
Hum Reprod. 2020 Feb 29;35(2):364-376
pubmed: 32106286
Reprod Sci. 2016 Oct;23(10):1371-80
pubmed: 27071964
Mech Ageing Dev. 2018 Jun;172:51-58
pubmed: 29132871
Nat Rev Endocrinol. 2014 May;10(5):261-75
pubmed: 24366116
Clin Proteomics. 2017 Feb 2;14:7
pubmed: 28174513
Am J Cancer Res. 2015 Apr 15;5(5):1706-17
pubmed: 26175939
Prostate. 2005 Apr 1;63(1):81-90
pubmed: 15468171
Cancer Res. 2008 Sep 15;68(18):7304-12
pubmed: 18794117
Arch Gynecol Obstet. 2011 Nov;284(5):1179-88
pubmed: 21197594
Immunol Cell Biol. 2001 Jun;79(3):291-7
pubmed: 11380683
J Transl Med. 2020 Dec 11;18(1):478
pubmed: 33308241
Gynecol Endocrinol. 2015 Jul;31(7):511-5
pubmed: 25986305
Oncogene. 2018 Apr;37(16):2197-2212
pubmed: 29391598
Proc Natl Acad Sci U S A. 2009 May 19;106(20):8221-6
pubmed: 19416857
J Minim Invasive Gynecol. 2020 Feb;27(2):452-461
pubmed: 31816389
Adv Wound Care (New Rochelle). 2013 Jun;2(5):195-214
pubmed: 24527343
Cell Signal. 2010 Aug;22(8):1163-74
pubmed: 20153821
Neoplasia. 2014 Jun;16(6):489-500
pubmed: 25077702
Hum Reprod Update. 2017 Sep 1;23(5):548-559
pubmed: 28903471
Circ Res. 2007 Oct 12;101(8):784-91
pubmed: 17704211
Carcinogenesis. 2008 Feb;29(2):252-62
pubmed: 17999987
Cell. 1993 Jul 2;73(7):1435-44
pubmed: 8391934
Cancer Invest. 2011 Feb;29(2):137-44
pubmed: 21261473
Cell Res. 2009 Jan;19(1):128-39
pubmed: 19114990
Mol Med Rep. 2018 Sep;18(3):3123-3136
pubmed: 30066912
Oncogene. 2010 May 20;29(20):2905-15
pubmed: 20208565
Mol Cell Biol. 2003 Jun;23(12):4371-85
pubmed: 12773577
Mol Cell Endocrinol. 2011 Jun 6;339(1-2):180-9
pubmed: 21550381
Int J Mol Sci. 2019 Dec 09;20(24):
pubmed: 31835434
Trends Endocrinol Metab. 2010 Mar;21(3):174-80
pubmed: 20005735
Cell. 1991 Nov 15;67(4):785-95
pubmed: 1657406
Oncogene. 2019 May;38(18):3402-3414
pubmed: 30643193
Cancer Res. 2007 Jun 1;67(11):5231-8
pubmed: 17522389
Int J Oncol. 2008 Oct;33(4):759-65
pubmed: 18813789
Biol Reprod. 2019 Apr 1;100(4):917-938
pubmed: 30423016